Research

rs11555236 — SIRT3

Intronic regulatory variant near the SIRT3 VNTR enhancer — the A allele increases SIRT3 expression and is linked to longevity in women

Moderate Protective Share

Details

Gene
SIRT3
Chromosome
11
Risk allele
C
Consequence
Intronic
Inheritance
Additive
Clinical
Protective
Evidence
Moderate
Chip coverage
v3

Population Frequency

AA
3%
AC
29%
CC
68%

Ancestry Frequencies

european
20%
east_asian
10%
latino
9%
south_asian
7%
african
5%

See your personal result for SIRT3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SIRT3 and the Mitochondrial Longevity Switch

Your mitochondria are not just energy factories — they are also the primary site of cellular aging. Every time they burn fuel, they generate reactive oxygen species 11 Reactive oxygen species (ROS) are chemically reactive molecules containing oxygen, such as superoxide and hydrogen peroxide, that damage DNA, proteins, and membranes if not rapidly neutralized that gradually damage the proteins, lipids, and DNA inside the cell. The gene SIRT3 encodes the master regulator of mitochondrial health: a NAD⁺-dependent deacetylase 22 A deacetylase removes acetyl groups from target proteins, changing their activity — analogous to flipping molecular on/off switches that controls dozens of mitochondrial enzymes governing energy production, fat oxidation, and antioxidant defense. SIRT3 is the only sirtuin with variants robustly linked to human longevity across multiple studies.

The rs11555236 variant sits in intron 5 of SIRT3, near a variable number tandem repeat (VNTR) enhancer33 variable number tandem repeat (VNTR) enhancer
A VNTR is a region of DNA where a short sequence is repeated a variable number of times. When this repeat region acts as an enhancer, it boosts transcription of nearby genes
that controls SIRT3 transcription. The A allele (reported as "T" in papers using minus-strand notation) is the protective allele: carriers show measurably higher SIRT3 protein levels, which translates to more active mitochondrial deacetylase activity.

The Mechanism

The SIRT3 intron 5 VNTR contains repeat units of 72 base pairs. A critical T-to-C transition within the second repeat of each VNTR unit determines whether a GATA2 transcription factor44 GATA2 transcription factor
GATA2 is a zinc finger transcription factor that binds specific DNA sequences and recruits the RNA polymerase machinery to activate gene transcription
binding site is present or absent. Bellizzi et al. and subsequent work by Bellizzi D et al.55 Bellizzi et al. and subsequent work by Bellizzi D et al.
Identification of GATA2 and AP-1 Activator Elements within the Enhancer VNTR Occurring in Intron 5 of the Human SIRT3 Gene. Mol Cells, 2009
demonstrated that GATA2 and c-Jun/c-Fos (AP-1) factors bind cooperatively to the repeat unit in an allele-specific manner, boosting SIRT3 transcription additively. The allele associated with the C genotype at rs11555236 (reported as G in papers, indicating the minus-strand C reference allele) has diminished enhancer activity; the A allele (minus-strand T) preserves the GATA binding site and drives higher SIRT3 expression.

With higher SIRT3 activity, several downstream processes are enhanced: SIRT3 deacetylates and activates SOD2 (superoxide dismutase 2), the primary mitochondrial superoxide scavenger; it deacetylates LCAD (long-chain acyl-CoA dehydrogenase), accelerating fat oxidation during fasting; and it activates FOXO3a within the mitochondrial matrix, promoting transcription of stress-resistance genes.

The Evidence

The most direct human evidence comes from the Treviso Longeva (TRELONG) prospective study66 Treviso Longeva (TRELONG) prospective study
Albani D et al. Modulation of human longevity by SIRT3 single nucleotide polymorphisms in the prospective study "Treviso Longeva (TRELONG)." Age (Dordr), 2014
, which followed 549 Italian elderly participants (age ≥70) for 7 years. In longitudinal mortality analysis, the hazard ratio for death was 0.58 for AA homozygotes versus CC homozygotes — a 42% reduction in mortality risk. Critically, this association was significant only in women (p=0.03), with no significant effect in men (p=0.52). Western blotting confirmed that AA homozygotes had significantly elevated SIRT3 protein in peripheral blood mononuclear cells compared to CC carriers, establishing the functional link between genotype and expression.

Earlier work by Bellizzi et al.77 Bellizzi et al.
A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics, 2005
found that the VNTR allele completely lacking enhancer activity was virtually absent in males older than 90, suggesting selection pressure in extreme aging. The related SNP rs4980329 was associated with longevity in the same TRELONG cohort.

At the cellular level, Hirschey et al.88 Hirschey et al.
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature, 2010
showed that SIRT3 knockout mice developed hallmarks of fatty-acid oxidation disorders during fasting — reduced ATP, cold intolerance, and accumulation of acylcarnitines — establishing SIRT3's essential role in metabolic flexibility. A breast cancer association study99 breast cancer association study
Yadav Payavula H et al. VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer. Asian Pacific J Cancer Prevention, 2023
found the no-repeat allele (OR 2.67, 95% CI 1.54-4.65) significantly over-represented in breast cancer cases, further supporting the functional importance of this enhancer region.

Evidence level is moderate: the longevity data are replicated but limited to Italian cohorts; the gender-specific effect requires independent validation.

Practical Implications

SIRT3 activity is tightly coupled to cellular NAD⁺ availability. This creates a leverage point: supplementing with NAD⁺ precursors — particularly nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) — provides more substrate for SIRT3's deacetylase activity regardless of genotype, but may be especially relevant for CC carriers who have lower baseline SIRT3 expression. Fasting, caloric restriction, and ketogenic dietary patterns all raise the NAD⁺/NADH ratio, similarly boosting SIRT3 function. A ketogenic diet study1010 ketogenic diet study
Hasan-Olive MM et al. A Ketogenic Diet Improves Mitochondrial Biogenesis and Bioenergetics via the PGC1α-SIRT3-UCP2 Axis. Neurochemical Research, 2019
found upregulation of SIRT3 via the PGC1α axis.

For CC homozygotes, the combination of lower SIRT3 expression and the role of SIRT3 in activating SOD2 (mitochondrial antioxidant) means that their SOD2 may be chronically under-activated — making SOD2 genotype (rs4880) relevant context for their total mitochondrial antioxidant capacity.

Interactions

The most important interaction partner is SOD2 (rs4880). SIRT3 is the primary activator of SOD2 through deacetylation: without adequate SIRT3, SOD2 remains in its acetylated, less-active state. A CC carrier at rs11555236 (lower SIRT3) who also carries the SOD2 Val allele (rs4880, reduced mitochondrial import) faces a compounded mitochondrial antioxidant deficit — lower SIRT3 expression means reduced activation of an already-reduced-capacity SOD2 enzyme. The combined recommendation for CC + SOD2 AA/AG individuals would emphasize aggressive mitochondrial antioxidant support (ubiquinol CoQ10, manganese, selenium) and NAD⁺ precursor supplementation.

FOXO3 (rs2802292) is a second interaction point: SIRT3 and FOXO3a form a functional complex in mitochondria that regulates the transcription of mitochondrial genes under caloric restriction. Both the SIRT3 A allele (rs11555236) and the FOXO3 G allele (rs2802292) are associated with longevity, and they operate through partially overlapping pathways — SIRT3 activating FOXO3 within mitochondria, FOXO3 upregulating SIRT3 transcription in response to stress. Carriers of protective alleles at both loci likely show synergistic benefits from caloric restriction and NAD⁺-boosting interventions.

Nutrient Interactions

NAD+ precursors (NMN/NR) altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant:

AA “Higher Expression” Beneficial

Two copies of the longevity-associated A allele — highest SIRT3 expression

Both copies of the SIRT3 VNTR enhancer in your cells carry the intact GATA2 and AP-1 binding sites, driving maximal SIRT3 transcription. The downstream consequences include:

  • More efficient SOD2 deacetylation and activation — better mitochondrial superoxide clearance.
  • Enhanced LCAD activity during fasting — superior fatty acid oxidation flexibility, a hallmark of metabolic health with aging.
  • Higher FOXO3a activation within mitochondria, coordinating stress-responsive gene expression.

The association with female longevity specifically (and the male survivorship finding for the VNTR allele in extreme old age) suggests sex-specific gene- environment interactions or hormonal modulation of the SIRT3 pathway that remain an active area of research.

Even with this favorable genotype, SIRT3 activity remains NAD⁺-dependent. Lifestyle factors that deplete NAD⁺ — sedentary behavior, chronic caloric excess, heavy alcohol use, aging itself — can still blunt the advantage conferred by higher SIRT3 expression.

AC “Intermediate Expression” Intermediate Caution

One copy of the longevity-associated A allele — intermediate SIRT3 expression

The additive model confirmed in the TRELONG study means heterozygotes receive a proportional, intermediate benefit from their single A allele. The one active VNTR enhancer copy drives modestly higher SIRT3 expression than CC, but not as high as AA.

The practical implication is that AC carriers sit in the middle of the SIRT3 expression distribution. Under normal metabolic conditions, this intermediate level may be sufficient. The genotype becomes most relevant under conditions that deplete NAD⁺ — chronic caloric excess, sedentary lifestyle, aging, and alcohol — all of which reduce the pool available to SIRT3.

CC “Lower Expression” Reduced Caution

Lower SIRT3 expression — reduced mitochondrial deacetylase activity

The VNTR enhancer in SIRT3 intron 5 regulates how much SIRT3 protein the cell produces. The C allele at rs11555236 is associated with reduced binding of the transcription factors GATA2 and AP-1 (c-Jun/c-Fos) to the repeat unit, leading to lower transcriptional output. With less SIRT3 available:

  • SOD2 (superoxide dismutase 2, the primary mitochondrial antioxidant) remains more heavily acetylated and less active, increasing mitochondrial oxidative stress.
  • LCAD (long-chain acyl-CoA dehydrogenase) remains more acetylated, reducing fatty acid oxidation efficiency during fasting or caloric restriction.
  • FOXO3a is less efficiently activated in the mitochondrial matrix, reducing the cell's transcriptional stress response.

The gender-specificity of the longevity finding (significant in women only in the TRELONG study) is not fully explained but may relate to sex-specific differences in mitochondrial function, hormonal interactions with SIRT3 pathways, or statistical power limitations of the 549-person cohort.

Key References

PMID: 23839864

TRELONG prospective study (n=549): rs11555236 T/A allele associated with female longevity (HR 0.58 for TT vs GG); TT carriers showed significantly elevated SIRT3 protein in PBMCs

PMID: 15676284

Bellizzi et al.: novel VNTR enhancer in SIRT3 intron 5 associated with survival at oldest ages; allele lacking enhancer activity virtually absent in males >90

PMID: 19714312

Identification of GATA2 and AP-1 activator elements in the SIRT3 VNTR; T>C transition in repeat unit ablates GATA binding site, creating allele-specific enhancer activity

PMID: 20203611

SIRT3 regulates mitochondrial fatty-acid oxidation by deacetylating LCAD at Lys42; SIRT3-null mice show hallmarks of fatty-acid oxidation disorders during fasting

PMID: 36974538

SIRT3 intron 5 VNTR 0R allele (no repeats/no enhancer) strongly associated with breast cancer risk (OR 2.67, 95% CI 1.54-4.65, p=0.000005)